探讨疏血通联合依达拉奉治疗老年脑梗死患者的临床疗效  

To Investigate the Clinical Effect of Shuxuetong Combined With Edaravone in the Treatment of Senile Cerebral Infarction

作　　者：刘玮[1] 赵丽波[1] 杨郁斐[1] 

机构地区：[1]黑龙江省医院内科,黑龙江哈尔滨150036

出　　处：《中国卫生标准管理》2017年第10期97-98,共2页China Health Standard Management

摘　　要：目的对老年脑梗死患者接受疏血通和依达拉奉联合治疗的临床效果进行分析,为临床治疗提供依据。方法选取我院接收的92例脑梗死患者作为研究对象,均是老年患者,年龄为68~87岁,将患者分组为对照组和治疗组,每组均有46例。对照组采用依达拉奉治疗,治疗组采用疏血通联合依达拉奉治疗,对两组的临床治疗效果进行比较分析。结果临床中,治疗组的治疗有效率为95.7%,对照组的临床治疗有效率为82.6%,两组结果对比,差异具有统计学意义(P<0.05)。结论老年脑梗死患者接受疏血通联合依达拉奉治疗的临床有效率高于单纯使用依达拉奉,不良反应少,临床中推介为脑梗死患者提供疏血通和依达拉奉联合治疗的方式,改善患者的临床症状。Objective To analyze the clinical effect of shuxuetong combined with edaravone in the treatment of elderly patients with cerebral infarction, and to provide the basis for clinical treatment. Methods 92 patients with cerebral infarction received in our hospital were selected as the research objects, all of them were elderly patients, the range of age was 68 - 87 years old. The patients were divided into control group and treatment group, 46 cases in each group. The control group was treated with edaravone, the treatment group was treated with Shuxuetong combined with edaravone, the clinical treatment effects of the two groups were compared and analyzed. Results The effective rate of the treatment group was 95.7%, the effective rate of clinical treatment in the control group was 82.6%, The difference between the two groups was statistically significant （P 〈 0.05）. Conclusion The clinical cerebral infarction in the elderly patients received shuxuetong injection combined with edaravone in the treatment efficiency is higher than the simple use of edaravone, less adverse reaction, is a very good way to provide treatment, promotion of edaravone combined with shuxuetong injection and treatment of patients with cerebral infarction clinical symptoms.

关 键 词：老年 脑梗死 疏血通 联合治疗 

分 类 号：R743.3[医药卫生—神经病学与精神病学]